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Abstract 
Objective: To evaluate agreement between instantaneous wave free ratio (iFR) and fractional flow reserve (FFR) for 
the functional assessment of nonculprit coronary stenoses at staged follow-up after ST-segment elevation myocardial 
infarction (STEMI).
Results: We measured iFR and FFR at staged follow-up in 112 STEMI patients with 146 nonculprit stenoses. Median 
interval between STEMI and follow-up was 16 (interquartile range 5–32) days. Agreement between iFR and FFR was 
77% < 5 days after STEMI and 86% after ≥ 5 days (p = 0.19). Among cases with disagreement, the proportion of cases 
with hemodynamically significant iFR and non-significant FFR were different when assessed < 5 days (5 in 8, 63%) ver-
sus ≥ 5 days (3 in 15, 20%) after STEMI (p = 0.04). Overall classification agreement between iFR and FFR was compara-
ble to that observed in stable patients. Time interval between STEMI and follow-up evaluation may impact agreement 
between iFR and FFR.
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Introduction
In patients with ST-segment elevation myocardial infarc-
tion (STEMI), nonculprit coronary stenoses may be iden-
tified [1]. Staged evaluation of these stenoses may rely on 
angiography alone, instantaneous wave free ratio (iFR), 
fractional flow reserve (FFR) or other invasive or nonin-
vasive methods [2].
In stable patients, the agreement between iFR and FFR 
in determining hemodynamic significance is approxi-
mately 80% [3]. In patients with recent myocardial infarc-
tion, baseline coronary blood flow may be increased 
while maximal hyperaemic blood flow may be decreased 
in both culprit and nonculprit arteries [2, 4]. Increased 
baseline flow will tend to lower iFR values leading to 
overestimation of the hemodynamic significance of 
stenoses, while decreased maximal hyperaemic blood 
flow will tend to increase FFR values leading to under-
estimation of the hemodynamic significance of stenosis 
[2, 4]. Thereby, recent myocardial infarction may affect 
the agreement between iFR and FFR compared to stable 
conditions.
In this iSTEMI (iFR in STEMI [5, 6]) substudy, we eval-
uated the agreement between iFR and FFR in nonculprit 
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Methods
The iSTEMI study has been described [5, 6]. Briefly, we 
measured nonculprit stenosis iFR in the acute STEMI 
setting and nonculprit stenosis iFR and FFR at staged 
follow-up. Nonculprit stenosis FFR was not measured 
in the acute STEMI setting.
In the current substudy, we examined agree-
ment between nonculprit stenosis follow-up iFR 
and FFR < 5  days after STEMI (corresponding to fol-
low-up during usual index admission duration) and 
after ≥ 5  days (corresponding to follow-up after usual 
index admission duration) after STEMI. In iSTEMI, 
time interval between STEMI and follow-up evaluation 
was at the discretion of the treating physicians.
Patients were recruited at Aarhus University Hospi-
tal (Denmark), Skåne University Hospital (Sweden), 
Örebro University Hospital (Sweden), VU University 
Medical Center (The Netherlands), and Hospital Prof. 
Doutor Fernando Fonseca (Portugal).
Intervals between STEMI and follow-up are pre-
sented as median (interquartile range). We considered 
iFR < 0.90 and FFR ≤ 0.80 hemodynamically significant. 
Proportions were compared using a proportion calcula-
tor (Stata/IC 13.1).
Results
The presented data are from 112 STEMI patients with 
completed follow-up iFR and FFR of 146 nonculprit 
stenoses [5]. We refer to the original publication for 
baseline patient data [5]. The median interval between 
STEMI and follow-up was 16 (5–32) days (Tables 1 and 
2).
In patients re-evaluated < 5  days after STEMI, there 
was classification agreement between iFR and FFR 
in 77% of nonculprit stenoses. When staged evalua-
tion was performed ≥ 5  days after STEMI, classification 
agreement was 86% (p = 0.19). Among cases with clas-
sification disagreement, the proportions of cases with 
hemodynamically significant iFR and non-significant 
FFR were different when assessed < 5  days (5 in 8, 63%) 
versus ≥ 5  days (3 in 15, 20%) after STEMI (p = 0.04). 
Individual values of follow-up iFR and FFR in patients 
with disagreement on nonculprit stenosis significance 
between iFR and FFR are presented in the Additional 
file 1.
Discussion
The time interval between myocardial infarction and nor-
malisation of baseline coronary blood flow and maximal 
hyperaemic blood flow remains uncertain and may differ 
between patients. The impact of these temporary blood 
flow changes on iFR may resolve before the impact on 
FFR and the impact on iFR may need more than 2 weeks 
to resolve [4–8].
In the current study, the time interval between STEMI 
and nonculprit stenosis evaluation did not impact the 
overall agreement between iFR and FFR. However, 
among cases with disagreement between follow-up iFR 
and FFR, iFR was more likely than FFR to indicate hemo-
dynamic significance < 5  days after STEMI whereas FFR 
was more likely than iFR to indicate hemodynamic sig-
nificance after ≥ 5  days. The observations after ≥ 5  days 
probably resemble observations in stable conditions 
more closely, i.e., FFR is more often significant than iFR 
with similar outcomes of revascularisation guided by iFR 
and FFR [9, 10]. Within < 5  days after STEMI, both iFR 
and FFR may be affected, but in opposite directions, and 
the optimal method for nonculprit stenosis evaluation in 
this setting remains undetermined [4–8]. Also, the opti-
mal time point for making this assessment remains to be 
established [2]. Different methods can be applied taking 
timing and potential bias of the used method in relation 
to timing into consideration [2]. In the acute or subacute 
setting, baseline flow may be increased and hyperemic 
flow may be decreased which may yield decreased iFR 
(overestimation of stenosis significance) and increased 
FFR (underestimation of stenosis significance) and these 
changes are expected to normalize over time although 
the time frame for this normalization is undetermined 
and may vary between patients [4–6].
In conclusion, in staged nonculprit stenosis evalua-
tion after STEMI, iFR and FFR has an overall agreement 
that is comparable to that observed in stable patients. 
Table 1 Agreement between  follow-up iFR and  FFR 
of nonculprit lesions < 5 days after STEMI
iFR, instantaneous wave free ratio. FFR, fractional flow reserve. STEMI, 
ST-segment elevation myocardial infarction. Follow-up interval: 2 (1–3) days
iFR ≥ 0.90 iFR < 0.90 Total
FFR > 0.80 11 5 16
FFR ≤ 0.80 3 16 19
Total 14 21 35
Table 2 Agreement between  follow-up iFR and  FFR 
of nonculprit lesions ≥ 5 days after STEMI
iFR, instantaneous wave free ratio. FFR, fractional flow reserve. STEMI, 
ST-segment elevation myocardial infarction. Follow-up interval: 28 (12–34) days
iFR ≥ 0.90 iFR < 0.90 Total
FFR > 0.80 60 3 63
FFR ≤ 0.80 12 36 48
Total 72 39 111
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However, the time interval between STEMI and follow-
up evaluation may impact agreement between iFR and 
FFR.
Limitations
The used cutoffs for iFR and FFR are based on previous 
studies and current clinical practice and derived from 
patients in stable condition. There was no clearly defined 
gold standard for ischemia detection. The cohort should 
ideally be a consecutive cohort, however, not all patients 
eligible patients were included during the study period. 
Without FFR in the acute setting, there is no information 
on the change in FFR.
The observed iFR values were clustered around the cut-
off for iFR. The distribution of iFR and FFR values may 
affect the agreement between the two methods. There 
was no data on microvascular obstruction or infarct size 
in these patients.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1310 4-020-05252 -6.
Additional file 1. Individual values of follow-up iFR and FFR in patients 
with disagreement on nonculprit stenosis significance between iFR and 
FFR.
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